Africa's healthcare sector is one of the fastest-growing in the world, driven by population growth, urbanisation, and increasing government health expenditure.
The African healthcare supply chain is characterised by chronic fragmentation, regulatory complexity, and financing constraints.
3-5 intermediaries between manufacturer and point of care. Each adds cost, delay, and provenance risk.
54 countries, each with distinct regulatory frameworks. No harmonised registration pathway.
Government procurement cycles of 6-18 months. Manufacturer payment delays of 90-180 days.
Limited cold chain infrastructure. WHO GDP compliance is aspirational, not operational, in most markets.
Four high-growth verticals where CSP's sovereign node model creates the most impact.
$600B+ global market. Africa imports >90% of devices.
Essential medicines, antiretrovirals, antimalarials.
Point-of-care testing, lab equipment, reagents.
Telemedicine, health records, AI diagnostics.
CSP eliminates the fragmentation problem by operating as a sovereign consolidation layer.
Traditional procurement relies on a chain of 3-5 intermediaries between manufacturer and point of care. Each intermediary adds cost, delay, and provenance risk. CSP replaces this entire chain with a single sovereign node — principal buyer authority, AI-powered matching, embedded compliance, and direct manufacturer relationships.
The result: specification to supply in hours rather than months, with full audit trail and zero intermediary markup.
22 active markets across East Africa, West Africa, and the Middle East.